Moroni Francesco, Spangaro Andrea, Carlino Mauro, Baber Usman, Brilakis Emmanouil S, Azzalini Lorenzo
Università Vita-Salute San Raffaele, Milan, Italy.
Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Int J Cardiol. 2020 Oct 15;317:200-206. doi: 10.1016/j.ijcard.2020.05.067. Epub 2020 May 26.
Renal impairment is associated with worse in-hospital and long-term outcomes after coronary artery revascularization, yet limited evidence is available on its impact on short- and long-term outcomes after chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
We conducted a systematic review of the literature and subsequent random-effect meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement to evaluate the effect of chronic kidney disease (CKD), defined as estimated glomerular filtration rate < 60 ml/min/1.73 m, on CTO PCI. The outcomes of this study were in-hospital death, procedural failure, contrast-induced acute kidney injury and all-cause death at follow-up.
Eight studies, with a total of 8439 patients (of whom 2256 had CKD) were included in the analysis. CKD was associated with higher technical (relative risk [RR] = 1.44, 95% confidence interval [CI] 1.14-1.82, p = .002) and procedural (risk ratio-RR = 1.40, 95% CI 1.00-1.96, p = .05) failure, higher in-hospital mortality (RR = 4.96, 95% CI 2.49-9.87 p < .001), bleeding complications (RR = 3.43, 95% CI 1.80-6.52, p < .001) and contrast-induced acute kidney injury (RR = 2.75, 95% CI 1.16-6.51, p = .001). CKD was also associated with higher all-cause mortality during long-term follow-up (RR = 3.56, 95% CI 1.08-5.99, p < .001).
Compared with patients with normal renal function, CKD is associated with lower success and higher risk of acute and long-term complications after CTO PCI. Kidney function should be considered during decision-making on CTO recanalization.
肾功能损害与冠状动脉血运重建术后更差的院内及长期预后相关,但关于其对慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)后短期和长期预后影响的证据有限。
我们根据系统评价和Meta分析的首选报告项目(PRISMA)声明对文献进行了系统评价及随后的随机效应Meta分析,以评估定义为估算肾小球滤过率<60ml/min/1.73m²的慢性肾脏病(CKD)对CTO PCI的影响。本研究的结局为院内死亡、手术失败、造影剂诱发的急性肾损伤及随访时的全因死亡。
八项研究共纳入8439例患者(其中2256例患有CKD)进行分析。CKD与更高的技术失败率(相对危险度[RR]=1.44,95%置信区间[CI]1.14-1.82,p=0.002)和手术失败率(风险比-RR=1.40,95%CI 1.00-1.96,p=0.05)、更高的院内死亡率(RR=4.96,95%CI 2.49-9.87,p<0.001)、出血并发症(RR=3.43,95%CI 1.80-6.52,p<0.001)及造影剂诱发的急性肾损伤(RR=2.75,95%CI 1.16-6.51,p=0.001)相关。CKD还与长期随访期间更高的全因死亡率相关(RR=3.56,95%CI 1.08-5.99,p<<0.001)。
与肾功能正常的患者相比,CKD与CTO PCI术后更低的成功率及更高的急性和长期并发症风险相关。在决定CTO再通时应考虑肾功能。